Trading Update

("Inspiration Healthcare", the "Company" or the "Group")

Trading Update

Inspiration Healthcare Group plc (AIM:IHC), the global medical technology company, is pleased to give a trading update for the six months ended 31 July 2022.

As was outlined in the Company's Annual General Meeting statement, published on 30 June 2022, the Group started the financial year strongly and the Company is pleased to report that trading levels have remained robust, consistent with management expectations.

The Company retains a strong order book and the expectation of second half weighting, as was indicated in our Annual General Meeting statement, continues, underpinned by patterns in customer ordering and current trading.

The move to new premises in Croydon has been completed and the benefits are clear to see, with a much-improved working environment for the enlarged group, better environmental efficiency, enhanced design and manufacturing facilities and improved logistic, storage and despatch operations. This makes the Group vastly more efficient and, therefore, capable of handling the ever-increasing volume of business and future growth.

Neil Campbell, Chief Executive Officer, commented, "We are continuing to see healthy sales levels across the entire Group and remain confident in achieving our targets for the year as a whole".

The Group will announce its Interim Results for the six months ended 31 July 2022 in early October 2022.

Enquiries:

About Inspiration Healthcare Group

www.inspirationhealthcaregroup.plc.uk

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries.  Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products.  The Group also acts as a distributor for 3rd party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS

The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

Further information on Inspiration Healthcare Group plc can be seen at  www.inspirationhealthcaregroup.plc.uk